NCT00197808

Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 392 (actual)
• Sponsor: Public Health England · Other Government
• Sex: All
• Age: 7 Weeks – 11 Weeks
• Healthy volunteers: Accepted

Summary

The purpose of the study is to evaluate the immune responses of UK infants after one or two doses of pneumococcal conjugate vaccine or one or two doses of three different types of meningococcal conjugate vaccine given at either two and three or two and four months of age.

Conditions

• Pneumococcal Infections
• Meningococcal Infections

Interventions

Type	Name	Description
BIOLOGICAL	menjugate	men C conjugate vaccine
BIOLOGICAL	Men C conjugate vaccine	men C conjugate vaccine
BIOLOGICAL	Men C conjugate	men C conjugate vaccine
BIOLOGICAL	Men C Conjugate	men C conjugate vaccine
BIOLOGICAL	Men C conjugate	men C conjugate vaccine
BIOLOGICAL	Men C conjugate	men C conjugate vaccine

Timeline

• Start date: 2005-04-01
• Primary completion: 2010-01-01
• Completion: 2010-01-01
• First posted: 2005-09-20
• Last updated: 2020-10-01

Locations

2 sites across 1 country: United Kingdom